Cite
Engineering chimeric antigen receptor T cells for solid tumour therapy.
MLA
Liu, Longwei, et al. “Engineering Chimeric Antigen Receptor T Cells for Solid Tumour Therapy.” Clinical & Translational Medicine, vol. 12, no. 12, Dec. 2022, pp. 1–21. EBSCOhost, https://doi.org/10.1002/ctm2.1141.
APA
Liu, L., Qu, Y., Cheng, L., Yoon, C. W., He, P., Monther, A., Guo, T., Chittle, S., & Wang, Y. (2022). Engineering chimeric antigen receptor T cells for solid tumour therapy. Clinical & Translational Medicine, 12(12), 1–21. https://doi.org/10.1002/ctm2.1141
Chicago
Liu, Longwei, Yunjia Qu, Leonardo Cheng, Chi Woo Yoon, Peixiang He, Abdula Monther, Tianze Guo, Sarah Chittle, and Yingxiao Wang. 2022. “Engineering Chimeric Antigen Receptor T Cells for Solid Tumour Therapy.” Clinical & Translational Medicine 12 (12): 1–21. doi:10.1002/ctm2.1141.